The Human Papillomavirus (HPV) Vaccine market Growth.of the Human Papillomavirus (HPV) Vaccine was valued at USD 4.12 billion in 2022. Projections indicate a significant growth, with an anticipated market value of USD 10.64 billion by 2030. This growth trajectory is expected to be driven by a Compound Annual Growth Rate (CAGR) of 12.6% over the forecast period from 2023 to 2030....